PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 31, 2018Drug Discovery Today1,843 citationsOpen Access

The rise of deep learning in drug discovery

View Full Paper
HCHongming ChenOEOla EngkvistYWYinhai Wang

Key Points

Key points are not available for this paper at this time.

Abstract

Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other machine learning algorithms in areas such as image and voice recognition, natural language processing, among others. The first wave of applications of deep learning in pharmaceutical research has emerged in recent years, and its utility has gone beyond bioactivity predictions and has shown promise in addressing diverse problems in drug discovery. Examples will be discussed covering bioactivity prediction, de novo molecular design, synthesis prediction and biological image analysis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2018) studied this question.

synapsesocial.com/papers/69d814828c03fbaff8bed883https://doi.org/10.1016/j.drudis.2018.01.039
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dropout: a simple way to prevent neural networks from overfitting2014 · 34,236 citations
  2. 2CSAR Benchmark Exercise of 2010: Selection of the Protein–Ligand Complexes2011 · 182 citations
  3. 3Going deeper with convolutions2015 · 47,236 citations
  4. 4ImageNet: Constructing a large-scale image database2010 · 293 citations
  5. 5Acoustics, Speech and Signal Processing (ICASSP), 2015 IEEE International Conference on2015 · 219 citations